Literature DB >> 2030106

Effect of adrenal demedullation and adrenaline on hypertension development and vascular reactivity in young spontaneously hypertensive rats.

K R Borkowski1.   

Abstract

1. The effects of adrenal demedullation and subcutaneous depots of adrenaline, on hypertension development and vascular reactivity, were determined in young spontaneously hypertensive rats (SHRs). 2. Plasma adrenaline, but not noradrenaline, was significantly lower in all 16-week-old demedullated SHRs, irrespective of the time of demedullation. However, hypertension development was attenuated only in SHRs demedullated at 6 weeks of age or younger. 3. Adrenaline depots restored hypertension development in SHRs demedullated at 4 weeks, irrespective of the time of depot implantation, but were without effect in sham-operated rats. 4. Pressor responses to exogenous noradrenaline, in isolated perfused mesenteric arteries from 16-week-old demedullated and sham-operated SHRs and those treated with adrenaline depots, did not differ significantly. Maximal neurogenic pressor responses were, however, reduced in mesenteries from all demedullated rats, including those treated with depot adrenaline. Adding adrenaline to the perfusate facilitated neurogenic responses only. 5. Thus, the adrenal medulla appears to be involved in modulating sympathetic neurogenic vasoconstriction. The nature of this sympathoadrenal interaction and its role in the early development of hypertension in the SHR is unclear and is not explicable simply in terms of a facilitation of sympathetic neurogenic responses by adrenaline.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030106     DOI: 10.1111/j.1474-8673.1991.tb00239.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  6 in total

1.  Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.

Authors:  R E de Boer; M R Steegstra; P A Kroezen; J Smit; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

2.  Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat.

Authors:  M L Jirout; R S Friese; N R Mahapatra; M Mahata; L Taupenot; S K Mahata; V Kren; V Zídek; J Fischer; H Maatz; M G Ziegler; M Pravenec; N Hubner; T J Aitman; N J Schork; D T O'Connor
Journal:  Hum Mol Genet       Date:  2010-04-08       Impact factor: 6.150

3.  Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.

Authors:  S Guimarães; A Albino-Teixeira; M Q Paiva
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Sustained prejunctional facilitation of noradrenergic neurotransmission by adrenaline as a co-transmitter in the portal vein of freely moving rats.

Authors:  R P Coppes; F Brouwer; I Freie; J Smit; J Zaagsma
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

Review 5.  The abnormalities of adrenomedullary hormonal system in genetic hypertension: Their contribution to altered regulation of blood pressure.

Authors:  A Vavřínová; M Behuliak; I Vaněčková; J Zicha
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

6.  Influence of Fimasartan (a Novel AT(1) Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats.

Authors:  Hyo-Jeong Lim; Seog-Ki Lee; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.